About
Dr Yogasakaran Arjuna
Dr Yogasakaran Arjuna
  • GP Partner, The Woodberry Practice
  • Clinical Director, Enfield South West PCN
  • Federation Director, Enfield GP Federation
  • Digital Clinical Lead, WNL ICB
Background

I am a frontline GP Partner and clinical leader working across practice, PCN, borough and North Central London system levels. My work focuses on improving primary care through better use of data, digital tools, population health management, clinical safety and practical service redesign.

I developed Arjus to support General Practice, PCNs and primary care leaders to better understand their data, identify unwarranted variation, prioritise improvement opportunities and make complex national and local datasets easier to use in day-to-day operational and clinical decision-making.

What is Arjus?

Arjus is a GP-built analytics and intelligence platform designed for primary care.

It brings together publicly available datasets, local dashboards and practical improvement tools to help practices, PCNs and system leaders make sense of performance, population health, workforce, access, contract delivery and patient outcomes.

The aim of Arjus is to turn complex data into clear, actionable insight — supporting better planning, safer care, improved patient outcomes and more informed conversations across primary care and the wider health system.

Who is Arjus for?

Arjus is intended for:

  • GP practices
  • Primary Care Networks
  • Clinical Directors
  • Practice managers
  • Federations and provider collaboratives
  • ICB and borough teams
  • Primary care transformation and digital leads

It is particularly designed for people who need to understand variation, monitor improvement, support contract delivery, and translate data into practical action.

Blog
NHS 10 Year Plan · Neighbourhood Health

Neighbourhoods, SNPs and MNPs: a plain-English guide

27 August 2026 · Dr Yogasakaran Arjuna

A year on from the 10 Year Health Plan, neighbourhood health has gone from slogan to consultation document. What SNP and MNP contracts actually are, how the local variation of the PCN DES fits in, what's protected, who might sit above your PCN at scale — and the consultation deadline of 10 September 2026 that general practice shouldn't miss. Fully referenced from NHS England, DHSC, Pulse and HSJ.

Read the guide
CVD Prevention · National Audit

CVDPREVENT: England, to March 2026

25 August 2026 · Dr Yogasakaran Arjuna

The March 2026 extraction is the first full quarter to show what happens when a fifth of QOF is torn up and re-aimed at cardiovascular prevention: blood pressure control hit a record high, lipid optimisation accelerated, smoking-cessation support fell off a cliff — and seven new indicators set the national baseline for SGLT2 inhibitors.

71.4%
BP controlled, hypertension <80 — record high
+4.7 pts
CVD patients at cholesterol target, year on year
−13.2 pts
Smokers offered cessation support
1 in 3
Eligible patients on an SGLT2 inhibitor — new baseline
Read the analysis Explore the CVDPREVENT dashboard
Contact

For questions, feedback or suggestions about Arjus, please contact:

Dr Yogasakaran Arjuna

Connect on LinkedIn

Arjus |
2023 ©

v1.0